BNT164b1
Candidate Overview
Sponsor / Lead Developer: BioNTech
Clinical Trial Status: Active Trials
Primary Indication: Prevention of TB disease
Target Population(s): Adolescents and Adults
Target Route of Administration: Intramuscular
Clinical Trials
ACTIVE TRIALS |
|
| Clinical Trial Phase | Phase 2a |
| Registry Number | NCT05547464 |
| Clinical Trial Sponsor | BioNTech SE |
| Primary endpoint(s) for this clinical trial | Safety |
| Target population(s) for clinical trial | Adults |
_________________________ |
|
| Clinical Trial Phase | Phase 1 |
| Registry Number | NCT05537038 |
| Clinical Trial Sponsor | BioNTech SE |
| Primary endpoint(s) for this clinical trial | Safety |
| Target population(s) for clinical trial | Adults |
_________________________ |
|
| Registry Number | NCT05547464 |
| Clinical Trial Phase | Phase 1 |
| Clinical Trial Sponsor | BioNTech SE |
| Primary endpoint(s) for this clinical trial | Safety |
| Target population(s) for clinical trial | Adults |